# Hub Cyber Security Ltd. (HUBCZ) — capital_raise/private_placement [announced]
Source: SEC API (secapi.ai) · situation sit_eb528c3dcd48fbe72df4 · retrieved 2026-08-11T15:49:41.900Z

## Overview
Evofem Biosciences, Inc. is a pharmaceutical company that develops and commercializes women's health products, including PHEXX and SOLOSEC.

Hub Cyber Security Ltd. acquired senior subordinated convertible notes and purchase rights of Evofem Biosciences, Inc. in two tranches. On June 30, 2026, Hub closed the June Private Placement, acquiring Evofem Notes with an aggregate outstanding balance of approximately $5,373,556 and June Purchase Rights of approximately $10,153,890, paying a total of approximately $49,331,891 through the issuance of 1,794,901 ordinary shares and pre-funded warrants to purchase 29,828,099 ordinary shares of Hub (at $1.560 per share). On July 21, 2026, Hub closed the July Private Placement, acquiring July Purchase Rights of approximately $4,000,000, paying $15,200,000 through the issuance of 590,107 ordinary shares and pre-funded warrants to purchase 9,543,226 ordinary shares of Hub (at $1.50 per share). The Evofem Notes are convertible at $0.0154 per share and bear 8% interest per annum, while the Purchase Rights are exercisable at the same price. Hub also acquired a $706,304 subordinated promissory note from Evofem on July 8, 2026, bearing 12% interest and maturing eleven months from issuance.

## Terms
- Counterparty: Evofem Biosciences, Inc. · Consideration: stock · Stake: 9.99% · Price/share: $0.0154

## Key dates
- Announced 2026-08-04

## Timeline
- 2026-08-04 · SCHEDULE 13D (0001213900-26-084888): SCHEDULE 13D - Hub Cyber Security Ltd. — *Evofem Biosciences, Inc. is a pharmaceutical company that develops and commercializes women's health products, including PHEXX and SOLOSEC.* Hub Cyber Security Ltd. acquired senior subordinated convertible notes and purchase rights of Evofem Biosciences, Inc. in two tranches. On June 30, 2026, Hub closed the June Private Placement, acquiring Evofem Notes with an aggregate outstanding balance of approximately $5,373,556 and June Purchase Rights of approximately $10,153,890, paying a total of approximately $49,331,891 through the issuance of 1,794,901 ordinary shares and pre-funded warrants to purchase 29,828,099 ordinary shares of Hub (at $1.560 per share). On July 21, 2026, Hub closed the July Private Placement, acquiring July Purchase Rights of approximately $4,000,000, paying $15,200,000 through the issuance of 590,107 ordinary shares and pre-funded warrants to purchase 9,543,226 ordinary shares of Hub (at $1.50 per share). The Evofem Notes are convertible at $0.0154 per share and bear 8% interest per annum, while the Purchase Rights are exercisable at the same price. Hub also acquired a $706,304 subordinated promissory note from Evofem on July 8, 2026, bearing 12% interest and maturing eleven months from issuance.
  https://www.sec.gov/Archives/edgar/data/1905660/0001213900-26-084888.txt

## Citations
- 0001213900-26-084888 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026084888